Flowserve Orders Hit Record as Middle East Dents Sales
Flowserve posted Q2 bookings of $1.35 billion, up 26% year over year, even as reported sales fell 2% to $1.2 billion and full-year organic sales guidance slipped to an approximately 1% decline. The en
Flowserve Books Record Orders, Cuts Sales Outlook
NEW YORK, August 13 —
Flowserve Corporation (FLS) is accumulating work faster than it can convert it. Q2 2026 bookings hit $1.35 billion, up 26% year over year, while reported sales fell 2% to $1.2 billion and full-year organic sales guidance slipped to an approximately 1% decline. The culprit is a single geography: Middle East disruptions have erased roughly $60 million of year-to-date organic revenue.
- Q2 bookings $1.35B, up 26% YoY; 1.15x book-to-bill; backlog grew 9% YoY excluding Trillium acquisition
- Q2 adjusted EPS $0.95, up 4% YoY; adjusted operating margin expanded 70 bps to 15.3% despite lower reported sales
- Full-year 2026 adjusted EPS guidance $4.05, $4.20, lower end raised; organic sales now guided to approximately 1% decline
The Order Book Knows Something the Revenue Line Does Not
Flowserve makes pumps, mechanical seals, and actuators under brands including Valtek, Limitorque, and Durco, selling to oil and gas producers, power generators, and chemical plants worldwide. Aftermarket repairs, replacements, and service contracts on installed equipment need no new project approvals. That segment generated nearly $700 million in Q2 2026 bookings, up 12% year over year, marking the ninth consecutive quarter above $600 million. Original equipment bookings added $650 million, up 44%, aided by large LNG awards and more than $110 million in nuclear orders. The order book shows end-market confidence the revenue line has not yet captured.
The Revenue Has Gone Missing, Not Cancelled
Year-to-date Middle East sales have fallen roughly $60 million, about three percentage points of organic growth foregone. The company's run-rate business in the region is down roughly 20%, and management projects similar conditions through year-end, with some projects slipping into 2027. Cancellation rates remain immaterial, meaning the orders exist but conversion has stalled; restoration work at damaged customer sites could add roughly $50 million of incremental bookings late in 2026 and beyond. That sequencing matters: it is a 2027 revenue catalyst, not a 2026 one, and the stock is priced at a moment when the damage is visible but the recovery is not.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| FLS | $10.2B | 17.2x | +52.7% |
| IEX | $17.5B | 24.8x | +43.9% |
| PNR | $10.6B | 12.7x | -38.3% |
| AME | $58.8B | 28.6x | +39.9% |
| FTI | $29.2B | 20.8x | +111.4% |
| DOV | $27.7B | 17.7x | +16.0% |
Middle East Timing Is the Only Variable That Matters Now
The bullish case is mechanical: a 1.15x book-to-bill points to approximately 5% second-half organic sales growth per management guidance, and four consecutive EPS beats averaging 12% suggest the $4.05, $4.20 guidance range may prove conservative. The Trillium Valves deal, closed June 30, also lifts Flowserve's estimated revenue per nuclear reactor from $100 million to roughly $115 million. The thesis turns on Middle East recovery timing: if disruption holds through 2027, the expected $50 million of restoration bookings and the broader project backlog sit idle. If conditions ease, the conversion math shifts the earnings story materially. Model the scenarios with the DCF calculator, or run the free Flowserve Corporation deep-dive at /stock/fls.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
What drove Flowserve Q2 2026 bookings higher?
Q2 bookings reached $1.35 billion, up 26% year over year, with original equipment orders of $650 million rising 44% on large LNG awards and more than $110 million in nuclear orders. Aftermarket bookings contributed nearly $700 million, marking the ninth consecutive quarter above $600 million.
Why did Flowserve cut its full-year organic sales outlook?
Middle East disruptions erased roughly $60 million of year-to-date organic revenue, with the region's run-rate business down approximately 20%. Management projects similar conditions through year-end, with some projects slipping into 2027, resulting in guidance for an approximately 1% organic sales decline for the full year.
What is Flowserve's full-year 2026 adjusted EPS guidance?
Full-year 2026 adjusted EPS guidance is $4.05 to $4.20, with the lower end raised. Four consecutive EPS beats averaging 12% over prior guidance suggest the range may prove conservative.
What does the Trillium Valves deal add to Flowserve?
The Trillium Valves acquisition, closed June 30, raises Flowserve's estimated revenue per nuclear reactor from $100 million to roughly $115 million. The deal deepens exposure to a nuclear market where Flowserve already booked more than $110 million in orders during Q2 2026.
What is Flowserve's current book-to-bill ratio?
Flowserve reported a 1.15x book-to-bill ratio in Q2 2026, with backlog growing 9% year over year excluding the Trillium acquisition. Management guidance points to approximately 5% second-half organic sales growth on the strength of that ratio.
Flowserve reported Q2 2026 bookings of $1.35 billion — up 26% year over year and driven by record aftermarket demand — while simultaneously cutting its full-year organic sales outlook to an approximately 1% decline. The company is adding to its pipeline faster than it can convert orders to revenue, and Middle East disruptions show no signs of easing before year-end.